In vitro studies have shown that IDH1 mutant cells are more sensitive to radiation therapy as compared to wild type cells and low grade and secondary IDH1 mutant gliomas show increased chemosensitivity [40,41,42]. Here, IDH1 is linked to central nervous system cancer.